After turning cystic fibrosis from a death sentence into a manageable condition for many patients, Vertex Pharmaceuticals is now looking to transform the treatment of
A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat amyotrophic lateral sclerosis with a
Researchers like to say that science is self-correcting, that knowledge is slowly but surely refined by new findings that build on or debunk old ones.
After spending decades fixated on a single hypothesis, Alzheimer’s researchers are increasingly searching for new ways to combat the devastating neurologic disease. One such approach
Jasper Therapeutics, a biotech looking to make stem cell transplants less taxing and to treat immune-mediated diseases, reported on Monday that its experimental drug helped
Over the past decade, there has been a clear and unprecedented exodus of young life scientists from academia and into lucrative industry jobs. But new
Over the past 150 years, humanity has unleashed unimaginable energy by splitting atoms and developed machines that allow us to soar through the skies. But
Exact Sciences won Food and Drug Administration approval on Friday for an improved version of a stool-based screening test for colon cancer that should result
Dupixent is already a blockbuster therapy for a range of immune-mediated diseases, but the Food and Drug Administration’s approval of the drug for chronic obstructive
Facing charges from the Securities and Exchange Commission for misleading claims related to a controversial Alzheimer’s drug candidate, Cassava Sciences and two of the company’s